Description
Description
Temzokey 250 mg
Composition: Temozolomide – 250 mg
Therapeutic Class: Anti-neoplastic
Aprazer’s Temzokey: Global Standard Anticancer Medicine
Temzokey is available worldwide in 50+ countries and is highly preferred due to affordability and high quality.
Aprazer Healthcare, global leaders in oncology care, develops international standard oncology treatments that are highly affordable and quality-efficient.
WHO- GMP certified, assured therapeutic efficacy and safety.
What is Temzokey?
Temzokey is an anticancer medicine used for various malignancies of the brain.
Uses of Temzokey
- • Glioblastoma multiforme
- • Anaplastic astrocytoma
- • Newly developed brain tumors
- • Recurrent brain tumors
- • Used as maintenance therapy to delay tumor progression and recurrence.
How does it work?
It alkylates DNA bases, breaking the cell integrity.
Causes cancer cell death.
Common Side Effects
- • Tiredness
- • Diarrhea
- • Nausea
- • Absence of periods in women
- • Risk of infections
- • Cough
- • Headache
- • Anemia
- • Hair loss
Serious Side Effects
- • Bone marrow depression
- • Bleeding in urine or stool
- • Life-threatening infections
- • Elevated liver enzymes
- • Cognitive dysfunction – confusion, seizures
- • Electrolyte imbalance
- • Risk of secondary malignancies – Acute Myeloid Leukemia or MDS
Precautions
To be used cautiously in patients with :
- • Secondary malignancies – MSD or acute myeloid leukemia
- • Liver disorders
- • Kidney disorders
- • Bleeding disorders
- • Immunocompromised conditions
- • Use of any myelosuppressive treatment
- • Elderly patients
- • Pediatric patients
Contraindications
- • Not to be used if any previous allergy or hypersensitivity to temozolomide or any excipients.
- • Breastfeeding mothers
- • Pregnant women
Warning
To be used under medical prescription only.
Safety and Monitoring Information
Regular monitoring of:
- • Liver function tests – ALT, AST, bilirubin
- • Neurological status – seizures, confusion
- • Hematologic profile- CBC
- • Opportunistic infections
Download Product PDF Attachment
